M. Tartary et al., DETECTION OF A MOLECULAR DEFECT IN 40 OF 44 PATIENTS WITH HEMOPHILIA-B BY PCR AND DENATURING GRADIENT GEL-ELECTROPHORESIS, British Journal of Haematology, 84(4), 1993, pp. 662-669
Oligonucleotides were computer designed to amplify by the polymerase c
hain reaction (PCR) the coding region, splice junctions, 112 bp of the
5' flanking region and 279 bp surrounding the polyadenylation site of
the factor IX gene for analysis by denaturing gradient gel electropho
resis (DGGE). Forty-four unselected haemophilia B patients were studie
d of whom 24 had severe haemophilia and 20 had a mild to moderate form
of the disease. Potential mutations were identified in 40 (91%) of th
e 44 cases. A defect could not be detected in three severe and one mil
d haemophiliac by DGGE analysis and direct sequencing of all the PCR f
ragments from these patients revealed no nucleotide alteration support
ing the DGGE results. A total of 37 point mutations, two complete gene
deletions and a duplication of 26 bp were found. The 37 point mutatio
ns included 35 single nucleotide substitutions, a deletion and an inse
rtion of one nucleotide. The 35 single nucleotide substitutions includ
ed 2 6 missense mutations, seven nonsense mutations, a G (-6) to A tra
nsition in the promoter region and a G (30154) to A transition within
the donor splice site of the last intron. Fifteen of these nucleotide
substitutions involved CpG dinucleotides. Fifteen point mutations were
found at codons where nucleotide substitutions had not been detected
before. An insertion of a single nucleotide T at position 6370 and del
etion of a G at nucleotide 30845 resulted in frameshift mutations crea
ting stop codons at amino acid positions -2 and 250, respectively. A d
uplication of 26 bp (17747-17772) in exon V was found in a severe haem
ophilia patient resulting in a termination codon in exon VI. The detec
tion of the mutation by the combined use of PCR, DGGE and direct seque
ncing was important for carrier diagnosis of 20 families with no prior
history of haemophilia B.